fbpx

MS may raise risk of long Covid

MS may raise risk of long Covid Published: 02 February 2022 A new study has found that almost a third of people with multiple sclerosis (MS) who get Covid-19 have symptoms lasting for at least a month.  Researchers reviewed more than 550 cases of people infected with Covid-19 who have
Read More

The effect of Covid-19 on multiple sclerosis symptoms

The effect of Covid-19 on multiple sclerosis symptoms Published: 27 April 2021 The majority of people with multiple sclerosis (MS) who catch Covid-19 go on to experience worsening of current symptoms, or new symptoms, a new survey has found.  The UK MS Register Covid-19 study launched in March 2020 to
Read More

New study looking for participants with multiple sclerosis

New study looking for participants with multiple sclerosis Published: 17 March 2021 Researchers are looking for people who found it difficult to return to work or school after receiving a diagnosis of multiple sclerosis (MS) or Covid-19 to take part in a survey to gather data on the health of
Read More

DMT does not increase risk of severe COVID-19

DMT does not increase risk of severe COVID-19 Published: 11 August 2020 Data from France has shown that for people with multiple sclerosis (MS), high scores on the expanded disability severity scale (EDSS), age, and obesity were linked as risk factors to more severe COVID-19 infections, but use of disease-modifying
Read More

Change in advice for those shielding

Change in advice for those shielding Published: 24 June 2020 Vulnerable and at-risk groups, including some people with multiple sclerosis (MS) will soon be able to spend time outside their homes, the Health and Social Care Secretary has announced.  From Monday 6 July, people shielding from COVID-19 will be able
Read More

Coronavirus guidance includes people taking immunosuppression therapies

Coronavirus guidance includes people taking immunosuppression therapies Published: 22 March 2020 The government has released further guidance relating to COVID-19 and has announced it will be sending letters out to 1.5 million people in England deemed most vulnerable due to health conditions.  This is known as ‘shielding’ and people who
Read More

Leading neurologists release coronavirus advice for people with MS

Leading neurologists release coronavirus advice for people with MS Published: 06 March 2020 A group of medical advisors for the MS Society, which includes some of the leading neurologists in the UK, have agreed the following joint statement on the COVID-19 coronavirus and MS:  “We have been closely following developments
Read More